{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:34:34Z","timestamp":1768350874692,"version":"3.49.0"},"reference-count":42,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2014,9,14]],"date-time":"2014-09-14T00:00:00Z","timestamp":1410652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100009933","name":"Ethicon","doi-asserted-by":"crossref","award":["19900"],"award-info":[{"award-number":["19900"]}],"id":[{"id":"10.13039\/100009933","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["NIH RO1-DK089547"],"award-info":[{"award-number":["NIH RO1-DK089547"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To identify the metabolic determinants of type 2 diabetes non\u2010remission status after bariatric surgery at 12 and 24 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 40 adults [mean \u00b1\n                      <jats:sc>sd<\/jats:sc>\n                      body mass index 36 \u00b1 3 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , age 48 \u00b1 9 years, glycated haemoglobin (\n                      <jats:styled-content style=\"fixed-case\">HbA1c<\/jats:styled-content>\n                      ) 9.7 \u00b1 2%) undergoing bariatric surgery [Roux\u2010en\u2010Y gastric bypass (\n                      <jats:styled-content style=\"fixed-case\">RYGB<\/jats:styled-content>\n                      ) or sleeve gastrectomy (\n                      <jats:styled-content style=\"fixed-case\">SG<\/jats:styled-content>\n                      )] were enrolled in the present study, the Surgical Treatment and Medication Potentially Eradicate Diabetes Efficiently (\n                      <jats:styled-content style=\"fixed-case\">STAMPEDE<\/jats:styled-content>\n                      ) trial. Type 2 diabetes remission was defined as\n                      <jats:styled-content style=\"fixed-case\">HbA1c<\/jats:styled-content>\n                      &lt;6.5% and fasting glucose &lt;126 mg\/dl (i.e. &lt;7 mmol\/l) without antidiabetic medication. Indices of insulin secretion and sensitivity were calculated from plasma glucose, insulin and C\u2010peptide values during a 120\u2010min mixed\u2010meal tolerance test. Body fat, incretins (glucagon\u2010like polypeptide\u20101, gastric inhibitory peptide, ghrelin) and adipokines [adiponectin, leptin, tumour necrosis factor\u2010\u03b1, high\u2010sensitivity C\u2010reactive protein (hs\u2010\n                      <jats:styled-content style=\"fixed-case\">CRP<\/jats:styled-content>\n                      )] were also assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At 24 months, 37 patients had available follow\u2010up data (\n                      <jats:styled-content style=\"fixed-case\">RYGB<\/jats:styled-content>\n                      , n = 18;\n                      <jats:styled-content style=\"fixed-case\">SG<\/jats:styled-content>\n                      , n = 19). Bariatric surgery induced type 2 diabetes remission rates of 40 and 27% at 12 and 24 months, respectively. Total fat\/abdominal fat loss, insulin secretion, insulin sensitivity and \u03b2\u2010cell function (C\u2010peptide\n                      <jats:sub>0\u2013120<\/jats:sub>\n                      \/glucose\n                      <jats:sub>0\u2013120<\/jats:sub>\n                      \u00d7 Matsuda index) improved more in those with remission at 12 and 24 months than in those without remission. Incretin levels were unrelated to type 2 diabetes remission, but, compared with those without remission, hs\u2010\n                      <jats:styled-content style=\"fixed-case\">CRP<\/jats:styled-content>\n                      decreased and adiponectin increased more in those with remission. Only baseline adiponectin level predicted lower\n                      <jats:styled-content style=\"fixed-case\">HbA1c<\/jats:styled-content>\n                      levels at 12 and 24 months, and elevated adiponectin correlated with enhanced \u03b2\u2010cell function, lower triglyceride levels and fat loss.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Smaller rises in adiponectin level, a mediator of insulin action and adipose mass, characterize type 2 diabetes non\u2010remission up to 2 years after bariatric surgery. Adjunctive strategies promoting greater fat loss and\/or raising adiponectin may be key to achieving higher type 2 diabetes remission rates after bariatric surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.12376","type":"journal-article","created":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T06:38:25Z","timestamp":1407739105000},"page":"1230-1238","source":"Crossref","is-referenced-by-count":53,"title":["Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non\u2010remission status after bariatric surgery"],"prefix":"10.1111","volume":"16","author":[{"given":"S. K.","family":"Malin","sequence":"first","affiliation":[{"name":"Department of Pathobiology Cleveland Clinic  Cleveland OH USA"},{"name":"Department of Nutrition Case Western Reserve University Cleveland Clinic  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bena","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences Cleveland Clinic  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Abood","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Diabetes and Metabolism, Cleveland Clinic  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E.","family":"Pothier","sequence":"additional","affiliation":[{"name":"Department of Bariatric and Metabolic Institute Cleveland Clinic  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. L.","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital and Harvard Medical School  Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Nissen","sequence":"additional","affiliation":[{"name":"Department of Heart and Vascular Cleveland Clinic  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Brethauer","sequence":"additional","affiliation":[{"name":"Department of Bariatric and Metabolic Institute Cleveland Clinic  Cleveland OH USA"},{"name":"Metabolic Translational Research Center Endocrine and Metabolism Institute, Cleveland Clinic  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. R.","family":"Schauer","sequence":"additional","affiliation":[{"name":"Department of Bariatric and Metabolic Institute Cleveland Clinic  Cleveland OH USA"},{"name":"Metabolic Translational Research Center Endocrine and Metabolism Institute, Cleveland Clinic  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Kirwan","sequence":"additional","affiliation":[{"name":"Department of Pathobiology Cleveland Clinic  Cleveland OH USA"},{"name":"Department of Nutrition Case Western Reserve University Cleveland Clinic  Cleveland OH USA"},{"name":"Metabolic Translational Research Center Endocrine and Metabolism Institute, Cleveland Clinic  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. R.","family":"Kashyap","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Diabetes and Metabolism, Cleveland Clinic  Cleveland OH USA"},{"name":"Metabolic Translational Research Center Endocrine and Metabolism Institute, Cleveland Clinic  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,9,14]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200111"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401329"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-012-0622-3"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318156f012"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.5835"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199509000-00011"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.14.1724"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2011.05.013"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-S011"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2009.11.003"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182a5034b"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.SLA.0000071560.76194.11"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-010-0198-8"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0246"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1089\/met.2013.0083"},{"key":"e_1_2_7_17_1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/HCO.0b013e3283642a33","article-title":"'Adiposopathy' and cardiovascular disease: the benefits of bariatric surgery","volume":"28","author":"Appachi SK","year":"2013","journal-title":"Curr Opin Cardiol"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-012-0589-0"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1596"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2013.196"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.41.3.368"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.4.6.871"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1089\/met.2007.0029"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-011-2059-5"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-012-0643-y"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.3945\/jn.111.139964"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-012-0473-3"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.976"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2598-x"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2007.03.002"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2011.07.009"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1535"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2007.08.004"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2538"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0511"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1176"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.11.042"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-0944-9"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0467"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.547"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00325.2002"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-013-0458-x"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1503\/cjs.026912"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdom.12376","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.12376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:20:44Z","timestamp":1761880844000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.12376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,14]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1111\/dom.12376"],"URL":"https:\/\/doi.org\/10.1111\/dom.12376","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,14]]}}}